Trump's Medical Report: What's Missing?

The White House has released a medical memorandum summarizing President Donald Trump's latest annual physical examination, conducted at Walter Reed National Military Medical Center. The President, who turns 80 in approximately two weeks, spent roughly three hours undergoing a series of medical tests. Navy Captain Sean Barbabella, the President's physician, authored the memorandum stating that Trump maintains excellent health across cardiac, pulmonary, neurological, and general physical categories. The cardiac assessment included a coronary CT angiography to check arterial conditions and echocardiogram and an AI-assisted electrocardiogram. AI analysis placed the President's estimated cardiac age at approximately 14 years, below his chronological age of 79. Several physicians who reviewed the document noted the absence of specific diagnostic metrics commonly associated with those tests, including calcium scoring, plaque measurements, arterial narrowing scores, and ejection fraction data, figures present in earlier presidential health disclosures. A carotid artery ultrasound was referenced in the report with results described as normal. No supporting numerical measurements were included alongside that finding. Trump's cholesterol readings were recorded as HDL at 70 mg per deciliter and LDL at 53 mg per deciliter. The President currently takes rosovastatin and ezet-meir to manage his cholesterol levels. The White House stated his numbers align with established cardiovascular prevention goals. The report acknowledged mild lower leg swelling, described as an improvement from the chronic venous insufficiency diagnosed during three separate Walter Reed visits last year. The report provided no explanation for the improvement. The White House noted that this condition's severity can fluctuate over time. Trump's PSA score, a prostate cancer screening marker, was recorded at 1 ng per mL, higher than prior readings but within a medically acceptable range. PSA levels typically rise with age. The White House stated that the absence of specific findings should be understood as confirmation that no clinically significant abnormalities were identified, and that medication lists and an executive level summaries are frequently condensed for readability. The White House also confirmed that monitoring and treatment of previously documented conditions continues regardless of whether those conditions appear in summary-level disclosures.